Abstract Individuals with posttraumatic stress disorder (PTSD) exhibit deficits in cognitive and emotional processes. PTSD severity is positively associated with anxiety sensitivity (AS) and difficulties in emotion regulation, and difficulties in emotion regulation mediate the relation between AS and PTSD. However, previous research has not examined the interactive nature of these variables.
processes is warranted given that such findings may contribute to improved treatment outcomes for individuals with comorbid PTSD and SUDs.
Accumulating evidence suggests that anxiety sensitivity (AS) is an important cognitive vulnerability factor that contributes to the development and maintenance of PTSD (Elwood et al. 2009; Fedoroff et al. 2000; Taylor 2003) . AS is conceptualized as the fear of anxiety-related sensations based on beliefs about their harmful physical, social, or cognitive consequences (Reiss and McNally 1985) . Interoceptive cues associated with AS and panic attacks are posited to exacerbate PTSD symptomatology (Hinton et al. 2008) , and in fact there is strong evidence for an association between AS and severity of concurrent and prospective PTSD symptoms (Asmundson et al. 1998; Feldner et al. 2006 Feldner et al. , 2008 . Furthermore, PTSD treatment has been shown to reduce AS severity (Gutner et al. 2013) . Notably, more severe AS is related to increased substance use among individuals with PTSD (Gillihan et al. 2011) .
While AS, a largely cognitive construct, appears to be integral to PTSD symptomatology, emotional processes are also theorized to be central to PTSD (Foa and Kozak 1986; Foa and Rothbaum 1998) . PTSD has been associated with a variety of difficulties in emotion regulation, defined as deficits in responding adaptively to emotions (Gratz and Roemer 2004) . PTSD-related difficulties include emotional suppression, lack of acceptance, limited access to effective regulation strategies, and lack of emotional clarity (Tull et al. 2007a; Moore et al. 2008; Ehring and Quack 2010) . Notably, PTSD has demonstrated significant associations with heightened emotional intensity and reactivity (Orsillo et al. 2004; Tull et al. 2007b) , thus requiring increased regulation efforts. For example, in a laboratory study, Badour and Feldner (2013) found a significant positive association between increased emotional reactivity to trauma narratives and posttraumatic stress symptom severity in individuals with high, but not low, emotion regulation difficulties. Moreover, in an effort to regulate emotions, individuals with PTSD often engage in maladaptive behavioral strategies, such as substance use (Khantzian 1997; Simpson et al. 2012) .
In order to more clearly delineate the functional relationship between AS and emotional vulnerability factors among trauma-exposed populations, researchers have evaluated these factors in individuals undergoing residential treatment for crack/cocaine dependence. In one study, probable PTSD participants demonstrated higher levels of emotion regulation difficulties and increased AS specific to social concerns (McDermott et al. 2009 ). Emotion regulation problems were uniquely predictive of PTSD status even when accounting for anxiety severity and the social concerns dimension of AS, which did not demonstrate unique variance in the model.
Similarly, a more recent study found that emotional avoidance and AS were uniquely predictive of PTSD symptom severity in substance-dependent patients even when accounting for anxiety severity and participant sex (Naifeh et al. 2012) . When emotional avoidance and AS were considered simultaneously, AS no longer significantly predicted PTSD severity, suggesting that the relationship between AS and PTSD was indirect through emotional avoidance. However, reverse mediation (i.e., the relationship between emotional avoidance and PTSD was indirect through AS) was also demonstrated. These findings lend further support for the roles of both AS and emotion regulation in PTSD status and symptom severity.
In previous studies, researchers' empirical questions have been about the relative influence of AS versus emotion regulation in predicting PTSD. However, there is also substantial evidence supporting an interactive relation between cognitive and emotional processes in PTSD (Hayes et al. 2012) . Given this evidence, it may be that both AS and emotion regulation operate together to influence the development and/or maintenance of PTSD. PTSD is characterized by threat-relevant interpretations of innocuous stimuli (Ehlers and Clark 2000) , including anxiety-related bodily sensations (Hinton et al. 2008; Wald and Taylor 2008) ; such appraisals elicit negative emotions (Tomaka et al. 1997) , which individuals with PTSD often have difficulty managing (van der Kolk et al. 1996) . Similarly, dysregulated emotions may activate AS by influencing the way that arousal is evaluated (Tull 2006) . For example, elevated fear can initiate threatrelated cognitions related to danger (e.g., emotional reasoning; ''I feel scared, so these sensations must be dangerous'') and negative consequences of fear (e.g., ''I might have a heart attack'').
Accordingly, the purpose of the current study was to examine the potential interaction of AS and difficulties in emotion regulation in predicting PTSD symptom severity among a residential SUD treatment sample. We expected that: (1) AS and difficulties in emotion regulation would be positively correlated; (2) AS and difficulties in emotion regulation would both positively correlate with PTSD symptom severity; and (3) AS and difficulties in emotion regulation would both contribute to each other in predicting PTSD severity. To test these hypotheses, we examined the interaction of AS and difficulties in emotion regulation in predicting PTSD symptom severity. Such an examination allows for the potential detection of: (1) a conditional effect of AS in predicting PTSD symptom severity based on levels of difficulties in emotion regulation; and (2) a conditional effect of difficulties in emotion regulation in predicting PTSD symptom severity based on levels of AS.
Method

Participants
Participants were recruited from an unlocked residential SUD treatment facility between 2008 and 2011. Inclusion criteria included diagnosis of current alcohol dependence and current PTSD related to a non-combat trauma according to DSM-IV-TR (APA 2000) criteria, and age between 18-60 years. Exclusion criteria included the presence of an acute psychotic disorder, bipolar disorder with an active manic episode, imminent risk for suicide, prescription medications that reduce cravings (e.g., naltrexone) or medications that reduce alcohol use (e.g., disulfiram), use of a benzodiazapine as determined by self-report or urine drug screen, a medical condition that might compromise the integrity of the data or limit cooperation (e.g., organic brain syndrome, dementia, head injury, neuropathy), illiteracy in English, and being involved in an ongoing abusive relationship that resulted in a DSM-IV-TR PTSD Criterion A event. A total of 700 individuals completed a brief prescreening of alcohol misuse and PTSD symptoms; 462 individuals did not meet screening criteria for inclusion in the study. Of the 238 individuals deemed eligible for the initial assessment, 222 completed the initial assessment. Of these, a total of 102 participants did not qualify for inclusion in the study because they did not meet criteria for PTSD and alcohol dependence or refused to participate.
The final sample included 120 participants (53.3 % male). Average age was 33.72 years (SD = 10.25). Participants self-identified as White (80 %), African-American (18.3 %), or ''Other'' (1.3 %). Alcohol and drug abuse or dependence was assessed using the Computerized Diagnostic Interview Schedule for DSM-IV (C-DIS-IV; Robins et al. 2000) and included marijuana (38.3 %), amphetamines (22.5 %), sedatives (35.8 %), cocaine/crack (58 %), and opiates (40.0 %). Current alcohol dependence was present in 100 % of the sample and 98.3 % of the sample met current dependence criteria for at least one illicit substance. A total of 84 participants (70 % of the sample) met criteria for at least one non-PTSD DSM-IV anxiety disorder (range 1-4 additional diagnoses; e.g., generalized anxiety disorder, panic disorder, social anxiety). Ninety-seven participants (80.8 %) met criteria for a current major depressive episode. Participants reported experiencing an average of 9.58 DSM-IV Criterion A traumatic events (SD = 5.00). The majority of participants endorsed the following Criterion A traumatic events: being attacked with a weapon (63.3 %); accidents (60.8 %); lifetime sexual assault (59.2 %); and being attacked without a weapon (55.0 %). Additionally, 40.0 % of participants reported childhood physical abuse and 36.7 % reported experiencing a natural disaster.
This study was part of a larger, Institutional Review Boardapproved treatment study. The goal of the larger study was to examine whether individuals with comorbid PTSD and SUDs exhibit improved outcomes if PTSD is treated during SUD treatment. Participants provided written informed consent and were compensated for their participation.
Measures
Screening Measures
The PTSD Checklist-Civilian Version (PCL-C; Weathers et al. 1993 ), a 17-item self-report measure of DSM-IV PTSD symptoms, was used as a screening measure to assess the likelihood for meeting diagnostic criteria for PTSD. Participants are asked how bothered they have been by each symptom over the past month. Items are rated on a 5-point scale (1 = not at all to 5 = extremely). The PCL-C exhibits high diagnostic efficiency (Buckley et al. 1996) and strong convergent validity with other measures of trauma-related problems (e.g., Weathers et al. 1993 ). Participants were eligible to participate if they met screening criteria established for civilians (i.e., C 44, Blanchard et al. 1996) .
The Alcohol Use Disorders Identification Test (AUDIT; Saunders et al. 1993 ), a 10-item measure assessing amount and frequency of drinking, symptoms of alcohol dependence, and negative consequences of alcohol use, was used to screen for likely alcohol dependence. Total scores range from 0 to 40; scores of 8 or above are indicative of likely hazardous or harmful alcohol use (Saunders et al. 1993) . The AUDIT has previously demonstrated validity and efficiency in identification of harmful alcohol use (de Meneses-Gaya et al. 2009 ).
Diagnostic Measures
The Clinician Administered PTSD Scale (CAPS; Blake et al. 1995) , a gold-standard structured clinical interview for DSM-IV PTSD symptoms, was used to diagnose current PTSD. The CAPS measures the frequency and severity of symptoms on a 4-point scale. A symptom was considered to be present when the past month frequency and severity ratings were at least 1 and 2, respectively (Weathers et al. 2001) . A total severity score is calculated by summing the frequency and severity ratings of the 17 symptoms of PTSD (possible range = 0-136). Internal consistency in the current study was good (a = .85) and interrater reliability for PTSD diagnosis was very good (kappa = .94). The National Women's Study PTSD Module (Resnick 1996) , a structured interview, was used to assess participants' trauma histories and establish PTSD Criterion A (APA 2000) event exposure. Cogn Ther Res (2015) 39:245-252 247 The Computerized Diagnostic Interview Schedule (C-DIS-IV; Robins et al. 2000) , a fully structured, computerized diagnostic interview for DSM-IV Axis I psychiatric disorders, was used to establish SUD diagnostic status. Participants were assigned diagnoses (i.e., no diagnosis, past or current abuse, past or current dependence) related to use of alcohol, marijuana, amphetamines, sedatives, cocaine/crack, opiates, PCP, hallucinogens, inhalants, and ''other'' drugs.
Self-report Questionnaires
The Difficulties in Emotion Regulation Scale (DERS; Gratz and Roemer 2004), a 36-item self-report measure, was used to assess six dimensions of emotion regulation difficulties. Participants endorse applicability of each item to themselves using a 5-point Likert scale (1 = almost never to 5 = almost always). Higher overall and subscale scores indicate more difficulty regulating emotions. For the current study, we used the revised 30-item five-factor model due to its improved psychometric properties (see Bardeen et al. 2012 ). The internal consistency of the 30-item DERS in the current sample was excellent (a = .93). The total score was highly correlated with the original 36-item version of the measure (r = .98, p \ .001).
The Anxiety Sensitivity Index (ASI; Reiss et al. 1986 ), a 16-item measure of anxiety about the negative consequences of arousal symptoms, was used to measure AS. ASI items are rated on a five-point scale (0 = ''very little'' to 4 = ''very much''). The ASI is a widely used, valid, and reliable measure (Peterson and Plehn 1999) . In the current sample internal consistency was good (a = .89).
Procedure
After hearing a brief description of the study, individuals expressing interest in the trial were administered the PCL-C and the AUDIT. Individuals whose scores on the PCL-C and AUDIT equaled or exceeded 44 and 8, respectively, were scheduled for an in-person clinical assessment to provide informed consent and determine study eligibility via structured diagnostic interviews. Upon giving informed consent, participants completed a comprehensive assessment battery, which included the CAPS, C-DIS-IV, DERS, and ASI.
Data Analysis
Analyses were conducted using SPSS version 20. Zeroorder correlation coefficients were used to assess relationships between study variables prior to analysis. PROCESS version 2.04 (Hayes 2013 ) was used to test the interaction of AS and DERS in predicting PTSD symptom severity. DERS and ASI scores were mean-centered prior to analysis to allow for meaningful interpretation of conditional effects. The Johnson-Neyman regions of significance analysis (Johnson and Neyman 1936) was used to probe the interaction. In addition, the pick-a-point technique (Rogosa 1980 ) was used to further explore the interaction at the DERS mean, one standard deviation below the mean, and one standard deviation above the mean.
Results
Means, standard deviations, and correlations between study variables are presented in Table 1 . The ASI and DERS were significantly positively associated and each variable was positively associated with PTSD symptom severity. Conditional process analysis results are presented in Table 2 . Conditional effects for both the ASI and DERS were not significant, while the interaction term (ASI X DERS) was a significant predictor of PTSD symptom severity (small effect, R 2 = .04). These findings indicate that AS and difficulties in emotion regulation interacted to predict PTSD symptom severity. That is, the association between AS and PTSD was conditional upon the severity of difficulties regulation emotion, and the association PTSD posttraumatic stress disorder, ASI anxiety sensitivity index, DERS difficulties in emotion regulation scale between difficulties in emotion regulation and PTSD was conditional upon AS severity. The Johnson-Neyman analysis of the interactive effect indicated that the ASI significantly predicted PTSD symptom severity when DERS scores were less than or equal to 86.18 (i.e., -.27 standard deviations below the DERS mean). The pick-a-point follow-up analysis revealed a significant conditional relationship between the ASI and PTSD symptom severity when DERS scores were held to one standard deviation below the mean (71.33), B = -.47, t(116) = 2.69, p = .008. The conditional relationship between ASI and CAPS was non-significant when DERS scores were held at the mean (91.72) and one standard deviation above the mean (112.11), B = -.20, t(116) = 1.46, p = .147 and B = -.07, t(116) = -.034, p = .732, respectively. Predicted PTSD symptom severity scores as estimated by the pick-a-point follow-up analysis are presented in Fig. 1 .
Discussion
Consistent with previous research, the current results demonstrated that AS and difficulties in emotion regulation are both associated with PTSD severity. As predicted, both AS and difficulties in emotion regulation had independent linear effects in predicting PTSD symptom severity (i.e., increased AS and difficulties in emotion regulation each predicted CAPS scores). Together, however, the effect was interactive, in that the relative effect of each predictor diminished as risk on the other predictor increased. For individuals with the highest levels of difficulties in emotion regulation, PTSD symptom severity was high regardless of level of AS. Conversely, for individuals with the highest levels of AS, increased PTSD symptom severity was observed regardless of level of difficulties in emotion regulation.
The current findings are partially consistent with our expectations, in that AS and difficulties in emotion regulation were operating in conjunction to predict PTSD symptom severity. However, this association only held in the context of low-to-moderate levels of AS and low-tomoderate difficulties in emotion regulation. The interaction finding suggests that, at heightened levels of severity, AS and difficulties in emotion regulation each exhibited influence on PTSD symptom severity in this sample of treatment-seeking, drug-and alcohol-dependent individuals.
Results of this study provide evidence for both cognitive and emotional conceptualizations of PTSD. The association between AS and PTSD symptom severity supports Ehlers and Clark's (2000) cognitive model of PTSD, wherein PTSD is characterized by negative cognitions about physical symptoms and emotional experiences. The finding that emotion regulation difficulties are associated with PTSD symptomatology is also consistent with emotional processing theories, which posit that individuals with PTSD limit and avoid exposure to trauma-related cues in an effort to reduce emotional reactivity (Foa and Kozak 1986; Foa and Rothbaum 1998) . Thus, we replicated previous research showing that both AS and difficulties in emotion regulation are relevant to PTSD, and provided an extension of this research through an integrated examination of how these cognitive and emotional factors operate together. Our findings suggest the possibility that extreme Fig. 1 Predicted PTSD symptom severity, measured with the Clinician Administered PTSD Scale (CAPS), as a function of scores falling at the mean, one standard deviation above the mean, and one standard deviation below the mean on the Anxiety Sensitivity Index (ASI) and Difficulties in Emotion Regulation Scale (DERS), respectively. Please note that the ASI and DERS scores are interchangeable on the axes, as this analysis focused on the interactive nature of both variables in predicting PTSD symptom severity Cogn Ther Res (2015) 39:245-252 249 AS or difficulties in emotion regulation may differentially affect the clinical presentation of PTSD symptoms. When interpreting these results, it is important to consider the limitations and strengths of the current study. The primary limitation of this study is the cross-sectional, correlational design, which precludes our ability to detect directionality of effects; future research should utilize longitudinal designs to enhance understanding of the precise influences of AS and difficulties in emotion regulation on PTSD development and maintenance. Additionally, the current study used the ASI to measure AS rather than the updated Anxiety Sensitivity Index -3 (ASI-3; Taylor et al. 2007 ). The psychometric properties of the two scales are generally comparable for assessment of global AS; however, the ASI-3 is superior for assessment of the AS subscales. As such, investigation of AS dimensions in the current study was not feasible. Given this limitation, examination of potential differential associations among AS social, cognitive, and physical concerns, difficulties in emotion regulation, and PTSD symptom severity is an important direction for future studies. One strength of the current study is that a clinical interview was administered to assess PTSD status, which represents an improvement over related studies (McDermott et al. 2009 ). Finally, previous investigations focused on a narrower population (i.e., predominantly African American, male crack/cocaine users; McDermott et al. 2009 ). Therefore, the current results may be more widely generalizable than previous studies.
Both AS and emotional avoidance have been associated with poor SUD treatment outcomes. For example, AS was found to be prospectively associated with SUD residential treatment dropout among heroin and crack/cocaine users (Lejuez et al. 2008) . Similarly, avoidance of emotional distress during behavioral tasks was retrospectively associated with self-reported duration of abstinence (Daughters et al. 2005a ) and prospectively associated with early treatment dropout (Daughters et al. 2005b) . In future studies researchers could examine whether these findings generalize to individuals with comorbid SUDs and PTSD, in that individuals with high levels of AS and/or difficulties in emotion regulation may exhibit more severe SUD symptomatology or poorer SUD treatment outcomes.
While cross-sectional in nature, our findings suggest that AS and difficulties in emotion regulation may interact mechanistically to predict and/or maintain PTSD. Considered in the context of previous research, results from this study provide additional, albeit preliminary, support for the potential benefit of interventions targeting AS and/or difficulties in emotion regulation (particularly emotional avoidance) among individuals with PTSD, depending on the manifestations of these difficulties in a particular client. The effectiveness of cognitive-behavioral interventions for PTSD is likely due to their targeting both cognitive and affective mechanisms of PTSD. However, patients with PTSD are quite heterogeneous. Within the context of established treatments, clinicians may consider measuring AS and emotion regulation difficulties during pre-treatment and emphasizing techniques that directly target the patient's most salient difficulties (e.g., emphasizing emotion regulation skills among individuals high in emotion regulation difficulties but lower in AS). As such, examination of the clinical utility of targeting specific cognitiveaffective processes in treatment-seeking individuals with comorbid PTSD and SUDs may be warranted. Future research could examine, for example, whether emphasizing specific treatment techniques based on patients' cognitiveaffective profiles improves treatment outcomes.
